Lack of correlation between expression of retinoic acid receptor-beta and loss of heterozygosity on chromosome band 3p24 in esophageal cancer

Genes Chromosomes and Cancer

Volumn 28, Issue 2, 2000, Pages 196-202

  Qiu, Hongming ^a   Lotan, Reuben ^a   Lippman, Scott M ^a   Xu, Xiao Chun ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOIC ACID RECEPTOR;

ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CHROMOSOME 3P; ESOPHAGUS CANCER; GENE LOCATION; HETEROZYGOSITY LOSS; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

CHROMOSOME BANDING; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 3; DNA, NEOPLASM; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; RECEPTORS, RETINOIC ACID;

EID: 0034015665     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(200006)28:2<196::AID-GCC8>3.0.CO;2-L     Document Type: Article

References (43)

1. Bartsch D, Boye B, Baust C, zur Hausen H, Schwarz E. 1992. Retinoic acid-mediated repression of human papillomavirus 18 transcription and different ligand regulation of the retinoic acid receptor beta gene in non-tumorigenic and tumorigenic HeLa hybrid cells. EMBO J 11:2283-2291.
2. 2 transgene. FASEB J 10:1091-1097.
3. Bix M, Locksley RM. 1998. Independent and epigenetic regulation of the interleukin-4 alleles in CD4+ T cells. Science 281:1352-1354.
4. Blot WJ, Li JY, Taylor PR. 1993. Nutritional intervention trials in Linxian, China: supplementation with specific vitamin/mineral combination, cancer incidence and disease-specific mortality in the general population. J Natl Cancer Inst 85:1483-1492.
5. Chambon P. 1996. A decade of molecular biology of retinoic acid receptors. FASEB J 10:940-954.
6. Cote S, Momparler RL. 1997. Activation of the retinoic acid receptor beta gene by 5-aza-2′-deoxycytidine in human DLD-1 colon carcinoma cells. Anticancer Drugs 8:56-61.
7. Cote S, Sinnett D, Momparler RL. 1998. Demethylation by 5-aza-2′-deoxycytidine of specific 5-methylcytosine sites in the promoter region of the retinoic acid receptor beta gene in human colon carcinoma cells. Anticancer Drugs 9:743-750.
8. de Thè H. 1996. Altered retinoic acid receptor. FASEB J 10:955-960.
9. de Thè H, Chomienne C, Lanotte M, Degos L, Dejean A. 1990. The t(15:17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor a gene to a novel transcribed locus. Nature 347:558-561.
10. Geben JF, Moghal N, Frangioni JY, Sugarbaker DJ, Neel BG. 1991. High frequency of retinoic acid receptor beta abnormalities in human lung cancer. Oncogene 6:1859-1868.
11. Geradts J, Chen J-Y, Russell EK, Yankaskas JR, Nieves L, Minna JD. 1993. Human lung cancer cell lines exhibit resistance to retinoic acid treatment. Cell Growth Differ 4:799-809.
12. Han J. 1993. Highlights of the cancer chemoprevention studies in China. Prev Med 22:712-722.
13. Hollander GA, Zuklys S, Morel C, Mizoguchi E, Mobisson K, Simpson S, Terhorst C, Wishart W, Golan DE, Bhan AK, Burakoff SJ. 1998. Monoallelic expression of the interleukin-2 locus. Science 279:2118-2121.
14. Hong WK, Lippman SM, Itri LM, Karp DD, Lee JS, Byers RM, Schantz SS, Kramer AM, Lotan R, Peters LL, Dimery IW, Brown BW, Goepfert H. 1990. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 323:795-801.
15. Houle B, Leduc F, Bradley WE. 1991. Implication of RARB in epidermoid (squamous) lung cancer. Genes Chromosomes Cancer 3:358-366.
16. Houle B, Rochette-Egly C, Bradley WE. 1993. Tumor-suppressive effect of the retinoic acid receptor beta in human epidermoid lung cancer cells. Proc Natl Acad Sci USA 90:985-989.
17. Hu L, Crowe DL, Rheinwald JG, Chambon P, Gudas LJ. 1991. Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell lines. Cancer Res 51:3972-3981.
18. Kato S, Mano H, Kumazawa T, Yoshizawa V, Kojima R, Masushige S. 1992. Effect of retinoid status on alpha, beta and gamma retinoic acid receptor mRNA levels in various rat tissues. Biochem J 286:755-760.
19. Kraemer KH, DiGiovanna JJ, Peck GL. 1992. Chemoprevention of skin cancer in xeroderma pigmentosum. J Dermatol 19:715-718.
20. Li JY, Taylor PR, Li B. 1993. Nutrition intervention trials in Linxian, China: multiple vitamin/mineral supplementation, cancer incidence and disease-specific mortality among adults with esophageal dysplasia. J Natl Cancer Inst 85:1492-1498.
21. Lippman SM, Lee JJ, Sabichi AL. 1998. Cancer chemoprevention: progress and promise. J Natl Cancer Inst 90:1514-1528.
22. Liu Y, Lee MO, Wang HG, Li Y, Hashimoto Y, Klaus M, Reed JC, Zhang XK. 1996. Retinoic acid receptor β mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells. Mol Cell Biol 16:1138-1149.
23. Lotan R, Xu X-C, Lippman SM, Ro JY, Lee JS, Lee JJ, Hong WK. 1995. Suppression of retinoic acid receptor β in premalignant oral lesions and its upregulation by isotretinoin. N Engl J Med 332:1405-1410.
24. Mangelsdorf DJ, Umesono K, Evans RM. 1994. The retinoid receptors. In: Sporn MB, Roberts AB, Goodman DS, editors. The retinoids, 2nd ed. New York: Raven Press, p 319-349.
25. Mao L, Lee DJ, Tockman MS, Erozan YS, Askin F, Sidransky D. 1994 Microsatellite alterations as clonal markers for the detection of human cancer. Proc Natl Acad Sci USA 91:9871-9875.
26. Moghal N, Neel BG. 1995. Evidence for impaired retinoic acid receptor-thyroid hormone receptor AF-2 cofactor activity in human lung cancer. Mol Cell Biol 15:3945-3959.
27. Ogasawara S, Maesawa C, Tamura G, Satodate R. 1995. Frequent microsatellite alterations on chromosome 3p in esophageal squamous cell carcinoma. Cancer Res 55:891-894.
28. Qiu H, Zhang W, El-Naggar AK, Lippman SM, Lotan R, Xu X-C. 1999. Loss of retinoic acid receptor-beta expression is an early event during esophageal carcinogenesis. Am J Pathol 155:1519-1523.
29. Roth AD, Morant R, Alberto P. 1999. High dose etretinate and interferon-alpha, a phase I study in squamous cell carcinomas and transitional cell carcinomas. Acta Oncol 38:613-617.
30. Seewaldt VL, Johnson BS, Parker MB, Collins SJ, Swisshelm K. 1995. Expression of retinoic acid receptor beta mediates retinoic acid-induced growth arrest and apoptosis in breast cells. Cell Growth Differ 6:1077-1088.
31. Shimada M, Yanagisawa A, Kato Y, Inoue M, Shiozaki H, Monden M, Nakamura Y. 1996. Genetic mechanisms in esophageal carcinogenesis: frequent deletion of 3p and 17p in premalignant lesions. Genes Chromosomes Cancer 15:165-169.
32. Slabber CF, Falkson G, Burger W, Schoeman L. 1996. 13-Cis-retinoic acid and interferon alpha-2a in patients with advanced esophageal cancer: a phase II trial. Invest New Drugs 14:391-394.
33. Sporn MB, Roberts AB, Goodman DS. 1994. The Retinoids: Biology, Chemistry, and Medicine. 2nd ed. New York: Raven Press.
34. Swisshelm K, Ryan K, Lee X, Tsou HC, Peacocke M, Sager R. 1994. Down-regulation of retinoic acid receptor β in mammary carcinoma cell lines and its up-regulation in senescing normal mammary epithelial cells. Cell Growth Differ 5:133-141.
35. Verma AK, Shoemaker A, Simsiman R, Denning M, Zachman RD. 1992. Expression of retinoic acid nuclear receptors and tissue transglutaminase is altered in various tissues of rats fed a vitamin A-deficient diet. J Nutr 122:2144-2152.
36. Wang L, Li W, Wang X, Zhang C, Zhang T, Mao X, Wu M. 1996. Genetic alterations on chromosomes 3 and 9 of esophageal cancer tissues from China. Oncogene 12:699-703.
37. Wu Q, Li Y, Liu R, Agadir A, Lee MO, Liu Y, Zhang X. 1997. Modulation of retinoic acid sensitivity in lung cancer cells through dynamic balance of orphan receptors nur77 and COUP-TF and their heterodimerization. EMBO J 16:1656-1669.
38. Xu X-C, Lotan R. 1999. Aberrant expression and function of retinoic acid receptors in cancer. In: Nau H, Blaner WS, editors. Handbook of experimental pharmacology: retinoids. Berlin: Springer-Verlag, p 323-343.
39. Xu X-C, Ro JY, Lee JS, Shin DM, Hong WK, Lotan R. 1994. Differential expression of nuclear retinoic acid receptors in normal, premalignant, and malignant head and neck tissues. Cancer Res 54:3580-3587.
40. Xu X-C, Stier U, Rosewicz S, El-Naggar A-K, Lotan R. 1996. Selective suppression of nuclear retinoic acid receptor beta gene expression in human pancreatic cancers. Int J Oncol 8:445-451.
41. Xu XC, Sneige N, Liu X, Nandagiri R, Lee JJ, Lukmanji F, Hortobagyi G, Lippman SM, Dhingra K, Lotan R. 1997a. Progressive decrease in nuclear retinoic acid receptor beta messenger RNA level during breast carcinogenesis. Cancer Res 57:4992-4996.
42. Xu X-C, Sozzi G, Lee JS, Lee JJ, Pastorino U, Pilotti S, Kurie JM, Hong WK, Lotan R. 1997b. Suppression of nuclear retinoic acid receptor β in non-small cell lung cancer in vivo: implications in lung cancer development. J Natl Cancer Inst 89:624-629.
43. Xu X-C, Liu X, Tahara E, Lippman SM, Lotan R. 1999. Expression and up-regulation of retinoic acid receptor-beta is associated with retinoid sensitivity and colony formation in esophageal cancer cell lines. Cancer Res 59:2477-2483.